Colombia has been on the map, surely when hunting at the cannabinoid planet from Europe, for the final two to 3 years. Judging by the quantity of participants who show up at International Cannabis Company Conferences, at least from this aspect of the planet, this is also not a casual discussion.
As of November, the game has clearly changed. For all of the speak about production in the nation, up till now, all the licensed grows had been for plants with significantly less than 1% THC.
This has now changed. The nation has issued its 1st license for the commercialization of “psychoactive” cannabis, in other words containing greater levels of THC. The recipient of the very same, Khiron Life Sciences Corp. also announced that it would use the license to generate higher THC extract to treat 15,000 individuals through the Latin American Institute of Neurology and the Nervous Program (or ILANS).
Beyond domestic distribution, what does this improvement bode for international markets?
Even though Germany is clearly on the minds of Khiron, a shrewd international operator with operations that currently attain to the UK and Germany (which includes assisting to provide cannabis for the British Project2021 project) this opens up other discussions a small closer to residence in the very same hemisphere. Namely, how extended will it be just before such organizations also commence to appear to each the Canadian and US markets?
Khiron, in certain, also has plans to provide Uruguay with complete-plant export, which is an ambitious move taking into consideration the nation is the only one particular in Latin America and nonetheless one particular of significantly less than a handful globally to legalize recreational use.
Nonetheless, it is this play alone which signifies that Khiron, along with other individuals that clearly establish themselves in such geography, is hunting at markets with higher have to have and expense sensitivity.
How expense-successful cannabis oil from Colombia is in the European hemisphere as additional neighborhood production starts to ramp up is an additional matter. See Greece, Portugal, and of course North Macedonia in the quick term.
This query is nonetheless in the area of course, along with the acceptance of healthcare GMP requirements for something coming out of the American hemisphere in common, specifically in the aftermath of CannTrust.
Regardless, it is clear that as an additional early mover Canadian decides to revamp and retool, which includes placing each European and Canadian plans to expand on indefinite hold that Latin America will play an increasingly larger part in the worldwide cannabis industry.